Ebola Vaccine Trial Underway In Liberia

vile and syringeThe World Health Organization (WHO) reports nearly 9,000 lives in West Africa have been lost to the Ebola epidemic that began March 2014 and this week human testing of two potential Ebola vaccines began in Liberia, reports the Associated Press.

Sign Up for the Black Doctor Newsletter!

 

The large-scale trial will be conducted on volunteers age 18 and older, with up to 600 volunteers participating in the first phase and as many as 27,000 taking part in total.

Both of the experimental vaccines – one developed by the National Institutes of Health and is being manufactured by GlaxoSmithKline; the other developed by Canadian health officials and is licensed to two U.S. companies, NewLink Genetics and Merck – tested safe for humans after initial smaller testing.